Over the past six months, shares of Strategy have experienced a notable decline, trading currently at $165.50. The stock has posted a disappointing 7.6% loss, significantly lagging behind the S&P 500’s robust gain of 10.8%. This downturn has raised questions among investors about their next steps regarding their holdings in Strategy, especially following its recent lackluster quarterly results.
Analysts express skepticism about investing in Strategy at this juncture, suggesting there may be more attractive opportunities available. Their analysis focuses on three key concerns that indicate potential underperformance for Strategy.
The first point highlighted is weak billings, which are often viewed as a proxy for cash revenue. These figures reflect the actual cash collected from customers during a specific time frame, differing from traditional revenue recognized over the duration of contracts. For Strategy, billings in the first quarter amounted to $83.17 million, with a year-on-year growth average of just 10.2% over the last four quarters. This tepid performance suggests that increasing competition is hindering the company’s ability to attract and retain customers.
The second concern revolves around a shrinking operating margin. While many software companies adjust profits to account for stock-based compensation (SBC), analysts prioritize GAAP operating margins, viewing SBC as a legitimate expense for talent acquisition. Strategy’s operating margin has seen a significant decline over the past two years, with the company posting a staggering negative 2,853% operating margin over the trailing 12 months. This stark figure indicates that the rising costs associated with operations are not being successfully passed on to customers.
The third major issue is related to cash burn, a critical factor for assessing financial health. Although Strategy reported positive free cash flow for the quarter, the overall picture is concerning. The company’s intense reinvestment activities have strained its financial resources, resulting in a free cash flow margin that averaged negative 18%—essentially burning $18 in cash for every $100 in revenue.
Given these factors, analysts contend that Strategy does not meet their quality investment standards. Currently trading at a high forward price-to-sales ratio of 109.6x, the stock reflects a significant amount of optimism about future performance, which might not be justified. They recommend that investors explore other opportunities that may offer better potential.
The analysts point to a list of growth stocks that have shown impressive revenue increases, indicating that strong revenue growth is a common trait among high-performing stocks. Names like Meta, CrowdStrike, and Broadcom have seen returns of 315%, 314%, and 455%, respectively. The analysis encourages investors to consider emerging opportunities, including well-known growth stocks and lesser-known businesses that are gaining traction.
In summary, while Strategy’s current share price may seem appealing, its underlying fundamentals raise several red flags that could deter investors from adding it to their portfolios. Instead, analysts suggest looking into alternative stocks that demonstrate more promising growth trajectories.
